Korea Omega Investment Corp
Seoul, Seoulkoreaomega.co.kr
Overview
Korea Omega Investment Corp. is a venture capital and private equity management firm established in April 2015. It is registered as a 'New Technology Business Finance Company' in South Korea. The firm invests in promising companies both in Korea and abroad, covering stages from early-stage venture and growth capital to private equity and buyouts. It is an affiliated company of KISWEL, an industrial enterprise. The firm's investment sectors include biotechnology, healthcare, IT, e-commerce, and digital content.
Portfolio Companies
6
Website
koreaomega.co.krInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| CROSSPOINT Therapeutics | Apr 2024 | Seed | Co-investor |
| Point2 Tech | May 2022 | Series B | Lead |
| iN Therapeutics | Feb 2021 | Series A | Co-investor |
| Aardark Therapeutics | Nov 2019 | Series A | Co-investor |
| ImmunoForge Co., Ltd. | Feb 2019 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.